Medical Director, Medical Affairs
Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. Rigel's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. Rigel's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy. In addition, Rigel has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics.
Reporting to the Head of Medical Affairs, the Medical Director provides specialist medical/scientific strategic and operational input into core medical affairs activities that span: health-care professional/provider interactions; generation of clinical and scientific data which may also include health economics and outcomes research (HEOR); educational initiatives (e.g., medical education, payer value dossier); safeguarding patient safety. Works closely with commercial teams to provide strategic medical input into core brand strategies and supports medical/marketing activities and market access. The Medical Director provides scientific and technical support for assigned products; deliver scientific presentations; develops and maintains professional and credible relationships with hematology and hematology/oncology key opinion leaders; provides strategic and tactical guidance to field MSLs, as well as relevant in-house training.
ESSENTIAL DUTIES AND RESPONSIBILITIES:
• Accountable and responsible for execution and delivery of the Medical Affairs Plan (in conjunction with the Head of Medical Affairs)
• Fulfills the role of Global Medical Lead for Medical affairs and is a member of the Fostamatinib Core Team
• Develops, reviews and follows up on clinical studies and medical projects initiated within the relevant therapeutic area (e.g. post marketing clinical activities such as registry/database projects, epidemiological surveys, post-authorization studies (phase IV), ISR projects, etc.)
• Interacts with and coordinates appropriate scientific and medical activities with internal stakeholders (i.e. commercial, clinical operations, discovery, statistics, regulatory, etc…) as they relate to on-going medical affairs projects
• Acquires public knowledge of present and future competitor products and how they impact the internal medical and commercial strategy
• Identifies data gaps that will inform the Investigator-Sponsored Research (ISR) program and HEOR initiatives
• Assist as consultant/liaison with other corporations when working under licensing agreements and/or in the evaluation of new business development opportunities, as needed
• Represents the medical function on cross-functional integrated teams for medical affairs 'activities. May represents Rigel at external meetings including investigator meetings, scientific association meetings, etc.
• Assists in the development of scientifically accurate marketing materials, medical education programs, advisories, and symposia
• In collaboration with MSLs, initiates, expands and maintains peer-to-peer KOL relationships aligned with Rigel’s therapeutic areas of interest
• Leads medical programs when required as part of post marketing requirements (e.g. Phase IV research)
• Supports other projects as required
• Travel up to 25 % of the time
KNOWLEDGE AND SKILL REQUIREMENTS:
• Medical Doctorate (M.D.) degree or equivalent (D.O. or non-US equivalent of M.D. meet requirements) with relevant therapeutic specialty in an academic or hospital environment
• Completion of residency and/or fellowship is preferred
• Therapeutic experience in hematology, hematology/oncology or autoimmune diseases strongly preferred
• 5+ years prior pharmaceutical/biotech industry experience is required, e.g. medical affairs or clinical development. Experience conducting HEOR studies a plus
• Interactions normally require the ability to gain cooperation of others, conduct presentations of technical information concerning specific projects/schedules, etc.
• Ability to interact externally and internally to support global business strategy. Must possess excellent oral and written English communication skills
• Proven record of being a successful medical leader
Rigel Pharmaceuticals Inc. is an Equal Opportunity Employer with a commitment to diversity.
All individuals are encouraged to apply